PRODUCTS SERVICES COMPANY CONTACT FAQ

Search Dictionary Mobile

Login

Cisplatin (Platino)

Subscribe to Selected New Research on Cisplatin

20223 relevant articles (2172 outcomes, 5188 trials/studies) found for this Drug

Description: An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle.

Also Known As:

Platino; cis-Platinum; Biocisplatinum; Dichlorodiammineplatinum; NSC-119875; Platidiam; Platinol; cis-Diamminedichloroplatinum; Diamminodichloride, Platinum; cis Diamminedichloroplatinum; cis Platinum; Platinum Diamminodichloride; cis-Diamminedichloroplatinum(II); cis-Dichlorodiammineplatinum(II); Platinum, diamminedichloro-, (SP-4-2)-

Relationship Network

Drug Context: Research Results

-

Inorganic Chemicals: 6

-

Platinum Compounds: 272

-

Cisplatin: 20223

*

TP protocol: 132

*

CPDD protocol: 121

*

transplatin: 49

*

VAB-IV protocol: 31

*

VMBP protocol: 25

*

M-VAC regimen: 23

*

cisplatin-DNA adduct: 22

*

FPEPIR regimen: 20

*

CISCA protocol: 18

*

diamminedichlorodihydroxyplatinum IV: 12

*

*

liposomal SPI-77: 11

*

CMF protocol: 9

*

ICE protocol 1: 8

*

BEP protocol: 6

*

*

*

MiPE protocol: 6

*

*

*

*

ESHAP regimen: 5

*

FAP protocol: 5

*

M-VAC protocol: 5

*

*

*

VAB-6 regimen: 5

*

VAB-III protocol: 5

*

ViFuP protocol: 5

*

DBPT regimen: 4

*

FLEP regimen: 4

*

BV-CAP protocol: 3

*

CAE-P protocol: 3

*

COPAC protocol: 3

*

DCM-Dex-CDDP: 3

*

EAP protocol: 3

*

*

ECT protocol: 3

*

*

PET protocol: 3

*

VIP protocol 2: 3

*

(diaminocyclohexane)(diacetato)(dichloro)platinum: 2

*

chlorodiethylenetriamine platinum: 2

*

cisplatin-deoxy(guanosine monophosphate guanosine) adduct: 2

*

cisplatin-procaine complex: 2

*

CVACE protocol: 2

*

HLFP regimen: 2

*

IAP protocol: 2

*

MAP protocol: 2

*

*

MVP protocol 2: 2

*

*

PMUE protocol 2: 2

*

*

selenium-cisplatin conjugate: 2

*

TAP protocol: 2

*

VP-P protocol: 2

*

ACV protocol: 1

*

APO protocol 2: 1

*

ASHAP protocol: 1

*

*

BCMV protocol: 1

*

BOP-CISCA-POMB-ACE regimen: 1

*

BOPP protocol: 1

*

CCE protocol: 1

*

CEP combination: 1

*

cis-diammineplatinum(II)-polyglutamic acid complex: 1

*

cisplatin-methionine: 1

*

CNR-NEO 2 protocol: 1

*

COB protocol: 1

*

COBDP regimen: 1

*

COMPA regimen: 1

*

COSS-86 protocol: 1

*

CPT protocol: 1

*

*

DCEP protocol: 1

*

DHAP protocol: 1

*

diamminediaqua platinum(II): 1

*

disodium hexachloroplatinate: 1

*

ESAP protocol: 1

*

EVAP regimen: 1

*

FCT protocol: 1

*

FEMTX-P protocol: 1

*

FLAP protocol: 1

*

FLAP regimen: 1

*

FLUDAP protocol: 1

*

FTP protocol: 1

*

GAP protocol: 1

*

HOP protocol: 1

*

M-VEC protocol: 1

*

MEC protocol 1: 1

*

MICE regimen: 1

*

modified ESHAP regimen: 1

*

*

OS 87 protocol: 1

*

PAVI protocol: 1

*

PBMF protocol: 1

*

PEP protocol: 1

*

PFL protocol: 1

*

PTP protocol: 1

-

Nitrogen Compounds: 37

-

Cisplatin: 20223

*

TP protocol: 132

*

CPDD protocol: 121

*

transplatin: 49

*

VAB-IV protocol: 31

*

VMBP protocol: 25

*

M-VAC regimen: 23

*

cisplatin-DNA adduct: 22

*

FPEPIR regimen: 20

*

CISCA protocol: 18

*

diamminedichlorodihydroxyplatinum IV: 12

*

*

liposomal SPI-77: 11

*

CMF protocol: 9

*

ICE protocol 1: 8

*

BEP protocol: 6

*

*

*

MiPE protocol: 6

*

*

*

*

ESHAP regimen: 5

*

FAP protocol: 5

*

M-VAC protocol: 5

*

*

*

VAB-6 regimen: 5

*

VAB-III protocol: 5

*

ViFuP protocol: 5

*

DBPT regimen: 4

*

FLEP regimen: 4

*

BV-CAP protocol: 3

*

CAE-P protocol: 3

*

COPAC protocol: 3

*

DCM-Dex-CDDP: 3

*

EAP protocol: 3

*

*

ECT protocol: 3

*

*

PET protocol: 3

*

VIP protocol 2: 3

*

(diaminocyclohexane)(diacetato)(dichloro)platinum: 2

*

chlorodiethylenetriamine platinum: 2

*

cisplatin-deoxy(guanosine monophosphate guanosine) adduct: 2

*

cisplatin-procaine complex: 2

*

CVACE protocol: 2

*

HLFP regimen: 2

*

IAP protocol: 2

*

MAP protocol: 2

*

*

MVP protocol 2: 2

*

*

PMUE protocol 2: 2

*

*

selenium-cisplatin conjugate: 2

*

TAP protocol: 2

*

VP-P protocol: 2

*

ACV protocol: 1

*

APO protocol 2: 1

*

ASHAP protocol: 1

*

*

BCMV protocol: 1

*

BOP-CISCA-POMB-ACE regimen: 1

*

BOPP protocol: 1

*

CCE protocol: 1

*

CEP combination: 1

*

cis-diammineplatinum(II)-polyglutamic acid complex: 1

*

cisplatin-methionine: 1

*

CNR-NEO 2 protocol: 1

*

COB protocol: 1

*

COBDP regimen: 1

*

COMPA regimen: 1

*

COSS-86 protocol: 1

*

CPT protocol: 1

*

*

DCEP protocol: 1

*

DHAP protocol: 1

*

diamminediaqua platinum(II): 1

*

disodium hexachloroplatinate: 1

*

ESAP protocol: 1

*

EVAP regimen: 1

*

FCT protocol: 1

*

FEMTX-P protocol: 1

*

FLAP protocol: 1

*

FLAP regimen: 1

*

FLUDAP protocol: 1

*

FTP protocol: 1

*

GAP protocol: 1

*

HOP protocol: 1

*

M-VEC protocol: 1

*

MEC protocol 1: 1

*

MICE regimen: 1

*

modified ESHAP regimen: 1

*

*

OS 87 protocol: 1

*

PAVI protocol: 1

*

PBMF protocol: 1

*

PEP protocol: 1

*

PFL protocol: 1

*

PTP protocol: 1

-

Chlorine Compounds: 4

-

Cisplatin: 20223

*

TP protocol: 132

*

CPDD protocol: 121

*

transplatin: 49

*

VAB-IV protocol: 31

*

VMBP protocol: 25

*

M-VAC regimen: 23

*

cisplatin-DNA adduct: 22

*

FPEPIR regimen: 20

*

CISCA protocol: 18

*

diamminedichlorodihydroxyplatinum IV: 12

*

*

liposomal SPI-77: 11

*

CMF protocol: 9

*

ICE protocol 1: 8

*

BEP protocol: 6

*

*

*

MiPE protocol: 6

*

*

*

*

ESHAP regimen: 5

*

FAP protocol: 5

*

M-VAC protocol: 5

*

*

*

VAB-6 regimen: 5

*

VAB-III protocol: 5

*

ViFuP protocol: 5

*

DBPT regimen: 4

*

FLEP regimen: 4

*

BV-CAP protocol: 3

*

CAE-P protocol: 3

*

COPAC protocol: 3

*

DCM-Dex-CDDP: 3

*

EAP protocol: 3

*

*

ECT protocol: 3

*

*

PET protocol: 3

*

VIP protocol 2: 3

*

(diaminocyclohexane)(diacetato)(dichloro)platinum: 2

*

chlorodiethylenetriamine platinum: 2

*

cisplatin-deoxy(guanosine monophosphate guanosine) adduct: 2

*

cisplatin-procaine complex: 2

*

CVACE protocol: 2

*

HLFP regimen: 2

*

IAP protocol: 2

*

MAP protocol: 2

*

*

MVP protocol 2: 2

*

*

PMUE protocol 2: 2

*

*

selenium-cisplatin conjugate: 2

*

TAP protocol: 2

*

VP-P protocol: 2

*

ACV protocol: 1

*

APO protocol 2: 1

*

ASHAP protocol: 1

*

*

BCMV protocol: 1

*

BOP-CISCA-POMB-ACE regimen: 1

*

BOPP protocol: 1

*

CCE protocol: 1

*

CEP combination: 1

*

cis-diammineplatinum(II)-polyglutamic acid complex: 1

*

cisplatin-methionine: 1

*

CNR-NEO 2 protocol: 1

*

COB protocol: 1

*

COBDP regimen: 1

*

COMPA regimen: 1

*

COSS-86 protocol: 1

*

CPT protocol: 1

*

*

DCEP protocol: 1

*

DHAP protocol: 1

*

diamminediaqua platinum(II): 1

*

disodium hexachloroplatinate: 1

*

ESAP protocol: 1

*

EVAP regimen: 1

*

FCT protocol: 1

*

FEMTX-P protocol: 1

*

FLAP protocol: 1

*

FLAP regimen: 1

*

FLUDAP protocol: 1

*

FTP protocol: 1

*

GAP protocol: 1

*

HOP protocol: 1

*

M-VEC protocol: 1

*

MEC protocol 1: 1

*

MICE regimen: 1

*

modified ESHAP regimen: 1

*

*

OS 87 protocol: 1

*

PAVI protocol: 1

*

PBMF protocol: 1

*

PEP protocol: 1

*

PFL protocol: 1

*

PTP protocol: 1